Referral to sub-specialists: who have the most to gain from early specialist intervention among patients with markers of renal disease?
Submitted: 27 September 2013
Accepted: 26 November 2013
Published: 19 December 2013
Accepted: 26 November 2013
Abstract Views: 1580
PDF: 966
HTML: 202
HTML: 202
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- Antonio Asti, Alessandra D'Alessandro, Francesco Paolo Zito, Salvatore Nardi, Giovanni Sarnelli, Giorgio Maresca, Giuseppe D'Alessandro, Sitagliptin versus saxagliptin in decompensated type 2 diabetes mellitus patients , Italian Journal of Medicine: Vol. 10 No. 1 (2016)
- Filippo Manelli, Maria Sofia Cotelli, Giovanni Lodoli, Stefano Bonetti, Marinella Turla, Cerebral microbleeds after COVID-19 infection: an Italian case report , Italian Journal of Medicine: Vol. 15 No. 3 (2021)
- Alessia Casola, Maria del Mar Jordana Sanchez, Simona Detrenis, Laura Bianchi, Sarah Pioli, Francesca Spagnoli, Michele Meschi, Evaluation of renal function in clinical practice: the basics , Italian Journal of Medicine: Vol. 13 No. 1 (2019)
You may also start an advanced similarity search for this article.